Celltrion, Foreign Investors Net Sell 12,729 Shares... Stock Price Down 1.51%
As of 12:32 PM on the 15th, Celltrion is trading at 337,000 KRW, up 1.51% from the previous day. This is a 9.16% decrease compared to February 1. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 12,729 shares of Celltrion, and institutions have net sold 12,000 shares, according to preliminary data. Over the past five days, individual investors have net bought 257,826 shares, while foreigners and institutions have net bought 127,547 shares and net sold 391,700 shares, respectively.
On February 8, Celltrion was a market topic with the headline "Celltrion surges following MFDS approval of COVID-19 antibody treatment."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
